UBS Group AG - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,151,055
+76.8%
82,016
+6.5%
0.00%0.0%
Q1 2023$1,782,273
-1.1%
76,988
+12.0%
0.00%0.0%
Q4 2022$1,801,617
+290.8%
68,764
+193.3%
0.00%
Q3 2022$461,000
+85.9%
23,448
+66.0%
0.00%
Q2 2022$248,000
-79.6%
14,126
-81.0%
0.00%
Q1 2022$1,217,000
+65.6%
74,414
+65.3%
0.00%
Q4 2021$735,000
+129.7%
45,026
+79.5%
0.00%
Q3 2021$320,000
+1900.0%
25,082
+2131.5%
0.00%
Q2 2021$16,000
+166.7%
1,124
+195.8%
0.00%
Q4 2020$6,0003800.00%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Parallel Advisors, LLC 5$00.00%
View complete list of CHINOOK THERAPEUTICS INC shareholders